Higher plasma levels of endocannabinoids and analogues correlate with a worse cardiometabolic profile in young adults.
Xinyu DiBorja Martinez-TellezElke H J KrekelsLucas Jurado-FasoliFrancisco J Osuna-PrietoLourdes Ortiz-AlvarezThomas HankemeierPatrick C N RensenJonatan R RuizIsabelle KohlerPublished in: The Journal of clinical endocrinology and metabolism (2023)
Our findings show that the plasma levels of eCBs and their analogues are related to higher levels of adiposity and worse cardiometabolic profile.